Prospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Endosc. Dec 16, 2024; 16(12): 668-677
Published online Dec 16, 2024. doi: 10.4253/wjge.v16.i12.668
Table 1 Baseline characteristics of eligible patients
Patient features

Number of patients202
Male, n (%)147 (72.8)
Age (years), mean ± SD69.9 ± 10.1
BMI (kg/m2), mean ± SD23.7 ± 3.6
Specimen size (mm), mean ± SD31.7 ± 12.8
Tumor location, n (%)
    Right colon81 (40.1)
    Left colon61 (30.2)
    Rectum60 (29.7)
Tumor morphology, n (%)
    0-Is/Ip88 (43.6)
    LST-G97 (48.0)
    LST-NG (0-IIc)17 (8.4)
ECOG performance status after ESD, n (%)
    0194 (96.0)
    ≥ 18 (4.0)
Table 2 Clinicopathological factors in the post-endoscopic submucosal dissection electrocoagulation syndrome and non-post-endoscopic submucosal dissection electrocoagulation syndrome groups

PECS group, n = 30Non-PECS group, n = 172P value
OR (95%CI)
Univariate analysis
Multivariate analysis
Sex, n (%)0.52
    Male21 (70.0)126 (73.3)
    Female9 (30.0)46 (26.7)
Age, n (%)0.54
    < 75 years17 (56.7)112 (65.1)
    ≥ 75 years13 (43.3)60 (34.9)
Specimen size, n (%)0.24
    < 30 mm11 (36.7)83 (48.3)
    ≥ 30 mm19 (63.3)89 (48.3)
Tumor location, n (%)1.00
    Right colon12 (40.0)69 (40.1)
    Left colon10 (33.3)51 (29.7)
    Rectum8 (26.7)52 (30.2)
Tumor morphology, n (%)0.85
    0-Is/Ip13 (43.3)75 (43.6)
    LST-G16 (53.4)81 (47.1)
    LST-NG (0-IIc)1 (3.3)16 (9.3)
Depth of pathological invasion, n (%)0.54
    Tis (M)28 (93.4)152 (88.4)
    T1a (SM < 1000 μm)1 (3.3)11 (6.4)
    T1b (SM ≥ 1000 μm)1 (3.3)9 (5.2)
Endoscopist, n (%)0.30
    Experts12 (40.0)54 (31.4)
    Trainees18 (60.0)118 (68.6)
Submucosal fibrosis, n (%)0.30
    Present6 (20.0)27 (15.7)
    Absent24 (80.0)145 (84.3)
ESD procedure time, n (%)0.180.16
    < 90 minutes11 (36.7)91 (52.9)1 (reference)
    ≥ 90 minutes19 (63.3)81 (47.1)1.76 (0.80-3.86)
Total Joule heat, n (%)< 0.01< 0.01
    Low Joule heat4 (13.3)105 (61.0)1 (reference)
    High Joule heat26 (86.7)67 (39.0)7.96 (2.91-21.8)
Table 3 Evaluation of the long procedure time group and short procedure time group

Long procedure time group (≥ 90 minutes), n = 100
Short procedure time group (< 90 minutes), n = 102
P value
Sex, n (%)0.75
    Male73 (73.0)73 (71.6)
    Female27 (27.0)29 (28.4)
Tumor location, n (%)0.67
    Right colon42 (42.0)38 (37.3)
    Left colon26 (26.0)35 (34.3)
    Rectum32 (32.0)29 (28.4)
ESD procedure performed by trainees, n (%)73 (73.0)63 (61.8)0.10
Submucosal fibrosis, n (%)24 (24.0)9 (8.8)< 0.01
PECS, n (%)19 (19.0)11 (10.8)0.33
Table 4 Cases of adverse events in the post-endoscopic submucosal dissection electrocoagulation syndrome and non-post-endoscopic submucosal dissection electrocoagulation syndrome groups

PECS group
Non-PECS group
Intraprocedural perforation or penetration/number of patients in each group1/305/172
ESD procedure performed by trainees/number of patients in each group1/305/172
Peak CRP (mg/dL), mean ± SD4.11 ± not applicable1.56 ± 1.42
Duration of hospitalization (days), mean ± SD6 ± not applicable6.2 ± 2.2